• For Researchers

Understanding early evolution of hard to treat cancer

Dr Phil Jones is using Programme Award funding to explore the earliest steps in the evolution of oesophageal cancer. Dr Phil Jones is using Programme Award funding to explore the earliest steps in the evolution of oesophageal cancer.

8 June 2017

• Health & Medicine

Combining immunotherapies could benefit some aggressive breast cancers

Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study. Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.

8 June 2017

• Science & Technology
• Health & Medicine

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017

• Health & Medicine

New chemotherapy approach offers breast cancer patients a better quality of life

The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF

6 June 2017

• Health & Medicine

Two clinical trials show promise with different targeted drugs for lung cancer

Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available. Two drugs targeting different gene faults in lung cancer have shown potential to be better than those already available.

6 June 2017

• Charity News

Statement on the death of Professor Patrick Johnston

Cancer Research UK statement on the death of Professor Patrick Johnston in Belfast. Cancer Research UK statement on the death of Professor Patrick Johnston in Belfast.

5 June 2017

• Health & Medicine

Ovarian cancer drug reduces chance certain advanced breast cancers will get worse

A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy. A drug that’s already approved to treat certain ovarian cancers holds some advanced breast cancers at bay longer than standard chemotherapy.

4 June 2017

• Health & Medicine

Combined immunotherapy could help control melanoma that has spread to the brain

A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease. A combination of two immunotherapy drugs is safe to give to patients with melanoma that has spread to the brain, and could help control the disease.

4 June 2017

• Science & Technology
• Health & Medicine

News digest – new drugs approved for lung cancer, wine glasses getting bigger, World No Tobacco Day and… cancer-causing shampoo?

New drugs approved for lung cancer, wine glasses getting bigger, World No Tobacco Day and… cancer-causing shampoo? Here's our weekly news digest. New drugs approved for lung cancer, wine glasses getting bigger, World No Tobacco Day and… cancer-causing shampoo? Here's our weekly news digest.

3 June 2017

• Health & Medicine

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread. Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

3 June 2017

• Health & Medicine

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent. Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

3 June 2017

• Policy & Insight

General Election 2017: What are the political parties promising for cancer and research?

A week away from the general election, we’ve put some of the manifestos under the microscope to see what they mean for cancer, research and patients. A week away from the general election, we’ve put some of the manifestos under the microscope to see what they mean for cancer, research and patients.

2 June 2017